During the past decade, Cancer Care Center of Southern Indiana conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 8 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Care Center of Southern Indiana" #1 sponsor was "Hoosier Cancer Research Network" with 10 trials, followed by "Chiron Corporation" with 2 trials sponsored, "Nasser Hanna, M.D." with 2 trials sponsored, "Cancer Biotherapy Research Group" with 1 trials sponsored and "CancerVax Corporation" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Care Center of Southern Indiana" #1 collaborator was "Walther Cancer Institute" with 5 trials as a collaborator, "Genentech, Inc." with 4 trials as a collaborator, "Hoosier Cancer Research Network" with 4 trials as a collaborator, "Indiana University School of Medicine" with 3 trials as a collaborator and "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Care Center of Southern Indiana" are "Breast Cancer" (4 trials), "Lymphoma, Non-Hodgkin" (3 trials), "Lung Cancer" (2 trials), "Metastatic Breast Cancer" (2 trials) and "Non-Small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "Cancer Care Center of Southern Indiana" in a lesser frequency.

Most popular intervention types in "Cancer Care Center of Southern Indiana" are "Drug" (22 trials), "Biological" (4 trials), "Procedure" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (5 trials), "Bevacizumab" (3 trials), "Cyclophosphamide" (3 trials), "Capecitabine" (2 trials) and "Cetuximab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Care Center of Southern Indiana" are 19 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Cancer Care Center of Southern Indiana". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Cancer Care Center of Southern Indiana, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Care Center of Southern Indiana, 4 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".